AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2013
Sep 4, 2013
35274_dirs_2013-09-04_6e453b78-6495-4c2f-91c4-6fb138b7b169.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2013-08-30
Reporting Person: GARR RICHARD (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-30 | Common Stock | J | 150000 | $0.00 | Disposed | 1131327 | Direct |
| 2013-08-30 | Common Stock | G | 50000 | $0.00 | Disposed | 1081327 | Direct |
| 2013-08-30 | Common Stock | G | 13000 | $0.00 | Disposed | 1068327 | Direct |
| 2013-08-30 | Common Stock | G | 13000 | $0.00 | Disposed | 1055327 | Direct |
| 2013-08-30 | Common Stock | G | 50000 | $0.00 | Acquired | 252000 | Indirect |
Footnotes
F1: The Reporting Person pledged 150,000 shares in exchange for a loan whereby the pledgee shall repay the 150,000 shares upon repayment of the loan in full.
F2: Disclosing a bonafide gift of 50,000 common shares.
F3: Disclosing a bonafide gift of 13,000 common shares.
F4: Disclosing a bonafide gift of 13,000 common shares.
F5: The Reporting person disclaims all beneficial ownership. Reporting person's spouse is receiving 50,000 common shares pursuant to estate planning.
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11